Acute Alcohol Withdrawal Protocol

Size: px
Start display at page:

Download "Acute Alcohol Withdrawal Protocol"

Transcription

1 Acute Alcohol Withdrawal Protocol Controlled document This document is uncontrolled when downloaded or printed Reference number Version 1 Author WHHT: C268 Dr Mohamed Shariff Date ratified August 2014 Committee/individual responsible Issue date August 2014 Review date August 2017 Target audience Key Words Previous Policy Name Gastroenterology Department Doctors and nurses of acute medical and surgical wards Alcohol, detoxification, detox, withdrawal, Chlordiazepoxide. N/A 1

2 Contribution List Key individuals involved in developing this version of the document Name Dr Mohamed Shariff Hayley Brookes Designation Consultant Gastroenterologist and Hepatologist, West Herts Hospitals NHS Trust Hospital Liaison Coordinator, Hertfordshire Drug and Alcohol Services, Spectrum Approved by Committee August 2014 (Gastroenterology Department Business meeting + awaiting Clinical Governance vember 2014) Change History Version Date Author Reason 2

3 CONTENTS Acute Alcohol Withdrawal Protocol... 1 Contribution List... 2 Introduction and Aim... 4 Withdrawal assessment and protocol... 5 Chlordiazepoxide prescribing regimen based on SADQ score and alcohol intake... 6 Severity of Alcohol Dependence Questionnaire (SADQ)... 7 CIWA-Ar Score Sheet... 8 References... 9 Equality Impact Assessment Policy and Procedure Sign-off Sheet Policy Ratification Form

4 Introduction and Aim In the UK, it is estimated that 24% of adults drink in a hazardous or harmful way that may put them at risk of acute alcohol withdrawal, seizures or delirium tremens 1. Successful detoxification will reduce the risk of these complications, although prescription regimens are highly variable and do not always take into account the severity of alcohol withdrawal. Based on NICE guidance, these protocol guidelines were written 1. Patients with acute alcohol withdrawal of patients at risk of developing alcohol withdrawal seizures or delirium tremens, should be offered admission to hospital for medically assisted alcohol withdrawal 1. Withdrawal severity scoring tools, such as the Severity of Alcohol Dependence Questionnaire (SADQ) and Clinical Institute Withdrawal Assessment Alcohol revised (CIWA-Ar) score should be used to gauge the severity of withdrawal and treatment should be individualised 1,2,3. This allows an objective measure of severity of alcohol withdrawal to be recorded and an appropriate regimen prescribed. In the UK, benzodiazepines are the most commonly used medications for acute alcohol withdrawal. Chlordiezopoxide and diazepam have UK marketing authorisation for this indication 1. The recommended dose of chlordiazopoxide for acute alcohol withdrawal in moderate to severe dependence should be 10 to 50mg in four daily doses 4. The protocol herein reflects this. 4

5 Withdrawal assessment and protocol 1. Individualise the alcohol withdrawal regimen to the patient. 2. The SADQ should be used FIRST to determine the appropriate withdrawal regimen (see below). 3. With all scheduled regimens, as required chlordiazepoxide 10-20mg must be prescribed and administered as per clinical need. 4. Ensure that Pabrinex is prescribed and administered. One pair of Pabrinex IVHP ampoules IV TDS for at least 1 day for known or suspected chronic alcohol misuser. Two pairs of Pabrinex IVHP ampoules IV TDS for 3-7 days for patients displaying symptoms of Wernicke s Encephalopathy (WE). If Pabrinex is not available/cannot be administered, prescribe Thiamine 100mg TDS PO and Vitamin B compound strong 2 tablets TDS. 5. Review the drug chart and ensure that no other additional benzodiazepines are prescribed. 6. The modified CIWA-Ar score sheet should then be used twice daily (by nurses or doctors on ward rounds) to assess whether further as required chlordiazepoxide is required. 7. If, on day 5, the patient is still requiring as required doses of chlordiazepoxide, their regimen should be reviewed. 8. If the patient becomes drowsy then medical assistance should be requested and no further doses of chlordiazepoxide be given. 9. Please refer patient to the Substance Misuse Liaison Team at the earliest opportunity by calling or

6 Chlordiazepoxide prescribing regimen based on SADQ score and alcohol intake SADQ 10 SADQ SADQ SADQ >40 Alcohol units per day 10 units units units >40 units Day mg prn 20mg qds 30mg qds 40mg qds (chlordiazepoxide) Day mg prn 15mg qds 20mg qds 30mg qds Day mg prn 10mg qds 15mg qds 20mg qds Day 4-10mg bd 10mg qds 15mg qds Day 5 - Stop 10mg bd 10mg qds Day Stop 10mg bd Day Stop + Chlordiazepoxide 10-20mg prn + Chlordiazepoxide 10-20mg prn 6

7 Patient Name: Ward: Hospital number NHS Number: Score 0 Date of birth: Almost Never Sometimes Often Nearly Always 1) I wake up feeling sweaty. 2) My hands shake first thing in the morning. 3) My whole body shakes violently first thing in the morning if I don t have a drink. 4) I wake up absolutely drenched in sweat. 5) I dread waking up in the morning. 6) I am frightened of meeting people first thing in the morning. 7) I feel on the edge of despair when I wake up. 8) I feel very frightened when I wake up. 9) I like to have a morning drink. 10) I always gulp down my morning drink as quickly as possible. 11) I drink in the morning to get rid of the shakes. 12) I have a very strong craving for a drink when I wake up. 13) I drink more than ¼ bottle of spirits or 4 pints of beer /1 bottle of wine per day. 14) I drink more than ½ bottle of spirits or 8 pints of beer /2 bottles of wine per day. 15) I drink more than 1 bottle of spirits or 15 pints of beer /4 bottles of wine per day. 16) I drink more than 2 bottle of spirits or 30 pints of beer /8 bottles of wine per day. Severity of Alcohol Dependence Questionnaire (SADQ) You have been completely off drink for a few weeks and then drink very heavily for two 0 days. How would you feel the morning after those two days of drinking?*: t at all 17) I would start to sweat. 18) My hands would shake. 19) My body would shake. 20) I would be craving a drink. *If the patient has not been abstinent for a period of two weeks then score maximum for Q Slightly 2 Moderately 3 A lot TOTAL SADQ SCORE= (Score 0-3= no dependence, 4-19= mild dependence, 20-30= moderate dependence, 31-44= severe dependence, 45+ = very severe dependence). 7

8 Patient Name: CIWA-Ar Score Sheet (Adapted from Sullivan et al, 1989) Hospital number NHS Number: 1. Perform twice daily to establish whether patient is receiving enough Chlordiazepoxide. Date of birth: 2. If patient appears over-sedated, call patient s team to assess if within working hours, Ward: Or, on call team if outside of working hours. Do not administer further Chlordiazepoxide before assessment. Is the patient A)Anxious B)Restless C)Aggressive Is the patient A)Shaky B)Sweating Is the patient experiencing hallucinations A)Auditory B)Visual Does the patient A)Feel sick B)Vomit Has the patient been sleeping well Time 10:00 18:00 10:00 18:00 10:00 18:00 10:00 18:00 10:00 18:00 Nursing/Doctor action taken Sign and Date Day 1 Day 2 Day 3 Day 4 Day 5 Day 6 Day 7 8

9 References 1. Alcohol-use Disorders: Diagnosis and clinical management of alcohol-related physical complications. NICE clinical guideline 100, June Sullivan JT, Sykora K, Schneiderman J, Naranjo CA, Sellers EM. Assessment of alcohol withdrawal: the revised clinical institute withdrawal assessment for alcohol scale (CIWA-Ar).Br J Addict v;84(11): Stockwell T, Hodgson R, Edwards G, Taylor C, Rankin H. The development of a questionnaire to measure severity of alcohol dependence. Br J Addict Alcohol Other Drugs Mar;74(1): British National Formulary, Edition 67, March

10 Equality Impact Assessment Yes/ Comments 1. Does the policy/guidance affect one group less or more favourably than another on the basis of: Race Ethnic origins (including gypsies and travellers) Nationality Gender Culture Religion or belief Sexual orientation including lesbian, gay and bisexual people Age Disability - learning disabilities, physical disability, sensory impairment and mental health problems 2. Is there any evidence that some groups are affected differently? 3. If you have identified potential N/A discrimination, are any exceptions valid, legal and/or justifiable? 4. Is the impact of the policy/guidance likely to be negative? 5. If so can the impact be avoided? N/A 6. What alternatives are there to achieving the policy/guidance without the impact? 7. Can we reduce the impact by taking different action? N/A N/A 10

11 Policy and Procedure Sign-off Sheet Policy Name and Number: Version Number and Date: : Service Location: PLEASE INSERT SERVICE LOCATION All staff members must sign to confirm they have read and understood this policy. Name Signature Name Signature 11

12 12

13 Policy Ratification Form Name of Document: Alcohol Withdrawal Policy Ratification Date: Name of Persons Job Title Date Divisional Support (Direct Line Manager / Matron / Consultant / Divisional Manager) Consultation Process (list of stakeholders consulted / staff groups presented to) Endorsement By Panel/Group Name of Committee Chair of Committee Date Document Checklist Yes / 1. Style & Format Is the title clear and unambiguous? Is the font in Arial? Is the format for the front sheet as per Appendix 1 of the policy framework Has the Trust Logo been added to the Front sheet of the policy? Is it clear whether the document is a guideline, policy, protocol or standard operating procedure? 2. Rationale Are reasons for development of the document stated? 3. Content Is there an introduction? Is the objective of the document clear? Does the policy describe how it will be implemented? Are the statements clear and unambiguous? Are definitions included? Are the responsibilities of individuals outlined? 4. Evidence Base Is the type of evidence to support the document identified explicitly? Are key references cited? Are supporting documents referenced? 13

14 Document Checklist 5. Approval Does the document identify which committee/group will approve it? 6. Review Date Is the review date identified? Is the frequency of review identified? If so is it acceptable? 7. Process to Monitor Compliance and Effectiveness Are there measurable standards or Key Performance Indicators to support the monitoring of compliance with and effectiveness of the document? Is there a plan to review or audit compliance with the document? Yes / Standard Equality Impact Assessment Tool Persons likely to be affected by policy change / Staff implementation Are there concerns that the proposed documentation / change could have an adverse impact on: Race. Ethnicity, National Origin, Culture, Heritage Religion, Faith, Philosophical Belief Gender, Marital Status, Pregnancy Physical or Learning Disabilities Mental Health Sexual Orientation / Gender Reassignment Age Homelessness, Gypsy / Travellers, Refugees / Asylum Seekers Please give details of any adverse impact identified: If adverse impacts are identified, are these considered justifiable? (Please give reasoning) There is unlikely to be an adverse impact on different minority groups Name of Person completing Ratification Form Job Title Date Ratification Group/Committee Chair Signature Date 14

Alcohol Detoxification (Inpatient) Prescribing Guidelines

Alcohol Detoxification (Inpatient) Prescribing Guidelines Alcohol Detoxification (Inpatient) Prescribing Guidelines Author: Sponsor/Executive: Responsible committee: Consultation & Approval: (Committee/Groups which signed off the procedure, including date) This

More information

Assessment Main title and management of alcohol dependence and withdrawal in the acute hospital: concise guidance

Assessment Main title and management of alcohol dependence and withdrawal in the acute hospital: concise guidance CONCISE GUIDANCE Clinical Medicine 01, Vol 1, No : 71 Assessment Main title and management of alcohol dependence and withdrawal in the acute hospital: concise guidance Author head name Stephen Stewart

More information

Prescribing for substance misuse: alcohol detoxification. Clinical background

Prescribing for substance misuse: alcohol detoxification. Clinical background Prescribing for substance misuse: alcohol detoxification POMH-UK Quality Improvement Programme. Topic 14a: baseline Clinical background 1 2014 The Royal College of Psychiatrists. For further information

More information

Interpreting & Translation Policy and Procedure

Interpreting & Translation Policy and Procedure Interpreting & Translation Policy and Procedure Controlled document This document is uncontrolled when downloaded or printed. Reference number Version 2 Author Name & Job Title Executive Lead WHHT: G026

More information

Guidelines for the In-Patient Management of Alcohol Withdrawal at Frimley Park Hospital NHS Foundation Trust

Guidelines for the In-Patient Management of Alcohol Withdrawal at Frimley Park Hospital NHS Foundation Trust Guidelines for the In-Patient Management of Alcohol Withdrawal at Frimley Park Hospital NHS Foundation Trust Authors: Dr Aftab Ala, Consultant Gastroenterologist & Hepatologist Dr Tasneem Pirani, ST4 in

More information

Guideline for the use of Naloxone in Adults

Guideline for the use of Naloxone in Adults Guideline for the use of Naloxone in Adults Controlled document This document is uncontrolled when downloaded or printed Reference number Version 1 Authors WHHT: MM098 Date ratified February 2016 Committee:

More information

Blood Glucose and Hyperglycaemia Management in Hospital for Adults with Diabetes Clinical Guideline V2.0. March 2018

Blood Glucose and Hyperglycaemia Management in Hospital for Adults with Diabetes Clinical Guideline V2.0. March 2018 Blood Glucose and Hyperglycaemia Management in Hospital for Adults with Diabetes Clinical Guideline V2.0 March 2018 Page 1 of 8 Summary flow chart for monitoring of blood glucose if >11mmol/L For Adults

More information

Acutely Painful testes

Acutely Painful testes 2.0 FINAL Guideline adopted from the Bedside Clinical Guideline Partnership EQUALITY IMPACT The Trust strives to ensure equality of opportunity for all both as a major employer and as a provider of health

More information

1.1. This guideline applies to medical, nursing and pharmacy staff in the safe and appropriate prescription and administration of acamprosate.

1.1. This guideline applies to medical, nursing and pharmacy staff in the safe and appropriate prescription and administration of acamprosate. SHARED CARE GUIDELINE FOR ACAMPROSATE 1. Aim/Purpose of this Guideline 1.1. This guideline applies to medical, nursing and pharmacy staff in the safe and appropriate prescription and administration of

More information

Patients undergoing Bariatric surgery with type 2 diabetes on antidiabetic drugs WITHOUT insulin, when starting liver shrinking diet: Guidance for GPs

Patients undergoing Bariatric surgery with type 2 diabetes on antidiabetic drugs WITHOUT insulin, when starting liver shrinking diet: Guidance for GPs Patients undergoing Bariatric surgery with type 2 diabetes on antidiabetic drugs WITHOUT insulin, when starting liver shrinking diet: Guidance for GPs Subject: Policy Number Ratified By: Patients with

More information

Education Pack for the Alcohol Liaison Nurse Service

Education Pack for the Alcohol Liaison Nurse Service Education Pack for the Alcohol Liaison Nurse Service Welcome to the Alcohol Liaison Nurse Service, this pack is designed to help you get the most out of your time here with us today and set some objectives

More information

Guidance for the care of pregnant women who have an alcohol misuse problem

Guidance for the care of pregnant women who have an alcohol misuse problem Document level: Clinical Service Unit (CSU) Code: DA1 Issue number: 2 Guidance for the care of pregnant women who have an alcohol misuse problem Lead executive Lead Clinical Director (Not for TW documents)

More information

NHS Fife Guidance for the Identification, Assessment and Management of Harmful Drinking and Alcohol Dependence

NHS Fife Guidance for the Identification, Assessment and Management of Harmful Drinking and Alcohol Dependence NHS Fife Guidance for the Identification, Assessment and Management of Harmful Drinking and Alcohol Dependence Staff working in services provided and funded by the NHS who care for people who potentially

More information

Lead for Gastroenterology Lee Dodge Alcohol Liaison 03/03/2015. Clive Gibson Safeguarding Adults Lead Nurse 03/03/2015

Lead for Gastroenterology Lee Dodge Alcohol Liaison 03/03/2015. Clive Gibson Safeguarding Adults Lead Nurse 03/03/2015 Acute Alcohol Withdrawal Management for Adult Inpatients Type: Clinical Guideline Register No: 1409 Status: Public on ratification Developed in response to: Best Practice Contributes to CQC Outcome number:

More information

SALBUTAMOL INHALER PATIENT GROUP DIRECTION CHILD HEALTH 1. Aim/Purpose of this Guideline

SALBUTAMOL INHALER PATIENT GROUP DIRECTION CHILD HEALTH 1. Aim/Purpose of this Guideline SALBUTAMOL INHALER PATIENT GROUP DIRECTION CHILD HEALTH 1. Aim/Purpose of this Guideline 1.1. This Patient Group Direction (PGD) applies to all nursing and clinical staff in the Child Health Department

More information

NCEPOD - Measuring the Units; A review of patients who died with alcohol-related liver disease

NCEPOD - Measuring the Units; A review of patients who died with alcohol-related liver disease NCEPOD - Measuring the Units; A review of patients who died with alcohol-related liver disease Hospital Number Admission to hospital 5. Trusts should ensure that medical patients are reviewed by a consultant

More information

Guideline for the use of Clonidine for Sedation in Adult Intensive Care

Guideline for the use of Clonidine for Sedation in Adult Intensive Care Guideline for the use of Clonidine for Sedation in Adult Intensive Care This guidance does not override the individual responsibility of health professionals to make appropriate decision according to the

More information

Pharmacological Therapy Policy Practice Guidance Note Management of Acute Alcohol Withdrawal in Adults (Over 18) - V01. Planned review: December 2017

Pharmacological Therapy Policy Practice Guidance Note Management of Acute Alcohol Withdrawal in Adults (Over 18) - V01. Planned review: December 2017 Pharmacological Therapy Policy Practice Guidance Note Management of Acute Alcohol Withdrawal in Adults (Over 18) - V01 V01 issued: Issue 1- Dec 14 Issue 2 April 17 Planned review: December 2017 PPT-PGN

More information

N-Acetylcysteine Dosing Guidelines for Paracetamol Overdose in Adults

N-Acetylcysteine Dosing Guidelines for Paracetamol Overdose in Adults N-Acetylcysteine Dosing Guidelines for Paracetamol Overdose in Adults This guidance does not override the individual responsibility of health professionals to make appropriate decision according to the

More information

Alcohol Withdrawal Guidelines

Alcohol Withdrawal Guidelines SH CP 197 Alcohol Withdrawal Guidelines Summary: Keywords: Target Audience: Identification, assessment and management of alcohol dependence and harmful alcohol use in people presenting for assessment or

More information

Pharmacological Therapy Policy Practice Guidance Note Management of Acute Alcohol Withdrawal in Adults (Over 18) - V02. Planned review: Dec 2020

Pharmacological Therapy Policy Practice Guidance Note Management of Acute Alcohol Withdrawal in Adults (Over 18) - V02. Planned review: Dec 2020 Pharmacological Therapy Policy Practice Guidance Note Management of Acute Alcohol Withdrawal in Adults (Over 18) - V02 Issue No: Issue 1- Dec 17 Planned review: Dec 2020 PPT-PGN 22 Part of NTW(C)38 Pharmacological

More information

GUIDELINES FOR ALCOHOL DETOXIFICATION AT HMP BEDFORD

GUIDELINES FOR ALCOHOL DETOXIFICATION AT HMP BEDFORD GUIDELINES FOR ALCOHOL DETOXIFICATION AT HMP BEDFORD Policy Details NHFT document reference MMG027/HMP Version 1 Date Ratified May 2017 Ratified by HMP Bedford Drugs and Therapeutics Committee Implementation

More information

Alcohol withdrawal including the Symptom triggered CIWA score Management

Alcohol withdrawal including the Symptom triggered CIWA score Management Alcohol withdrawal including the Symptom triggered CIWA score Management Classification: Policy Lead Author: Ruth Brown Alcohol specialist Nurse Additional author(s): Hailey Pennington Authors Division:

More information

SHARED CARE GUIDELINE FOR BUCCAL MIDAZOLAM FOR THE TREATMENT OF PROLONGED SEIZURES IN CHILDREN

SHARED CARE GUIDELINE FOR BUCCAL MIDAZOLAM FOR THE TREATMENT OF PROLONGED SEIZURES IN CHILDREN SHARED CARE GUIDELINE FOR BUCCAL MIDAZOLAM FOR THE TREATMENT OF PROLONGED SEIZURES IN CHILDREN 1. Aim/Purpose of this Guideline 1.1. This guideline applies to medical, nursing and pharmacy staff in the

More information

Guidance For The Detoxification Of Alcohol Dependent Patients In Community Or Outpatient Settings

Guidance For The Detoxification Of Alcohol Dependent Patients In Community Or Outpatient Settings Guidance For The Detoxification Of Alcohol Dependent Patients In Community Or Outpatient Settings Co-ordinators: Fiona Raeburn, Specialist Pharmacist in Substance Misuse Reviewer: Dr Seonaid Anderson,

More information

Clinical Guideline for Intravenous Opioids for Adults in Recovery Areas The Recovery Protocol

Clinical Guideline for Intravenous Opioids for Adults in Recovery Areas The Recovery Protocol Clinical Guideline for Intravenous Opioids for Adults in Recovery Areas The Recovery Protocol 1. Aim/Purpose of this Guideline 1.1. To Provide safe and efficient administration of Opioids in Recovery.

More information

Patient Group Directions Policy

Patient Group Directions Policy Patient Group Directions Policy Category: Summary: Equality Analysis undertaken: Valid From: Date of Next Review: Approval Date/ Via: Distribution: Related Documents: Author(s): Further Information: This

More information

ALCOHOL WITHDRAWAL GUIDELINES

ALCOHOL WITHDRAWAL GUIDELINES ALCOHOL WITHDRAWAL GUIDELINES Policy author Accountable Executive Lead Approving body Policy reference Dr M Lewis, Gastroenterologist; Professor J A Vale, Clinical Toxicologist; Dr D A Robertson, Alcohol

More information

Guidelines for the Management of Dyspepsia and GORD. Gastroenterology/ Acute Adult Governance. Drugs and Therapeutics Committee

Guidelines for the Management of Dyspepsia and GORD. Gastroenterology/ Acute Adult Governance. Drugs and Therapeutics Committee Guidelines for the Management of Dyspepsia and GORD Document type: Version: 3.0 Author (name): Author (designation): Validated by Prescribing Dr. G. Lipscomb Date validated October 2015 Ratified by: Date

More information

University Hospitals of Leicester NHS Trust

University Hospitals of Leicester NHS Trust University Hospitals of Leicester NHS Trust ACUTE ALCOHOL WITHDRAWAL MANAGEMENT Guidelines for Management of Acute Medical Emergencies Approved By: Policy and Guideline Committee Date Approved: 21 November

More information

Trust Policy 218 Ionising Radiation Safety Policy

Trust Policy 218 Ionising Radiation Safety Policy Trust Policy 218 Ionising Radiation Safety Policy Purpose Date Version August 2016 7 To ensure that Plymouth Hospitals NHS Trust complies with all relevant legislation with regard to the use of ionising

More information

INPATIENT ALCOHOL WITHDRAWAL PRESCRIBING GUIDELINES MAY 2018

INPATIENT ALCOHOL WITHDRAWAL PRESCRIBING GUIDELINES MAY 2018 INPATIENT ALCOHOL WITHDRAWAL PRESCRIBING GUIDELINES MAY 2018 Policy title Inpatient alcohol withdrawal Prescribing Guidelines Policy PHA28B reference Policy category Clinical Relevant to Trust-wide any

More information

Alcohol Issues in the Acute General Hospital Setting

Alcohol Issues in the Acute General Hospital Setting Alcohol Issues in the Acute General Hospital Setting (Guidelines and Management) This procedural document supersedes: PAT/T 25 version 3 - Guidelines for the Management of Alcohol Issues in the Acute General

More information

MEDICALLY ASSISTED COMMUNITY ALCOHOL WITHDRAWAL GUIDELINES SEPTEMBER 2015

MEDICALLY ASSISTED COMMUNITY ALCOHOL WITHDRAWAL GUIDELINES SEPTEMBER 2015 MEDICALLY ASSISTED COMMUNITY ALCOHOL WITHDRAWAL GUIDELINES SEPTEMBER 2015 This policy supersedes all previous policies for medically assisted community alcohol withdrawal Policy title Guidelines for medically

More information

Guidelines on Medical Treatments for Substance Misuse. May Tayside Substance Misuse Service

Guidelines on Medical Treatments for Substance Misuse. May Tayside Substance Misuse Service Guidelines on Medical Treatments for Substance Misuse May 2015 Tayside Substance Misuse Service Introduction Tayside Substance Misuse Service (TSMS) TSMS comprises the specialist NHS elements of the comprehensive

More information

CLINICAL GUIDELINE FOR THE ADMINISTRATION OF MESNA WITH IFOSFAMIDE AND CYCLOPHOSPHAMIDE Summary.

CLINICAL GUIDELINE FOR THE ADMINISTRATION OF MESNA WITH IFOSFAMIDE AND CYCLOPHOSPHAMIDE Summary. CLINICAL GUIDELINE FOR THE ADMINISTRATION OF MESNA WITH IFOSFAMIDE AND CYCLOPHOSPHAMIDE Summary. Yes Is patient prescribed ifosfamide or cyclophosphamide >1g/m 2? Chemotherapy prescription on Aria should

More information

Translation and Interpretation Policy

Translation and Interpretation Policy Translation and Interpretation Policy Version 1 Ratified By NHS West Cheshire Clinical Commissioning Group Governing Body Date Ratified 16 th November 2017 Author(s) Jonathan Taylor Responsible Committee

More information

Trust Policy. Control of Smoking Policy (Patients and Visitors)

Trust Policy. Control of Smoking Policy (Patients and Visitors) Trust Policy Control of Smoking Policy (Patients and Visitors) Purpose Date May 2016 Version V3 Final To discharge the Trust s responsibilities under the Health Act 2006, and associated NICE Guidelines

More information

GUIDELINE FOR ENTERAL TUBE FEEDING (NASOGASTRIC OR PEG) IN PATIENTS WITH DIABETES MELLITUS TREATED WITH INSULIN

GUIDELINE FOR ENTERAL TUBE FEEDING (NASOGASTRIC OR PEG) IN PATIENTS WITH DIABETES MELLITUS TREATED WITH INSULIN GUIDELINE FOR ENTERAL TUBE FEEDING (NASOGASTRIC OR PEG) IN PATIENTS WITH DIABETES MELLITUS TREATED WITH INSULIN This guidance does not override the individual responsibility of health professionals to

More information

Bleeding / Pain after Renal Biopsy Guideline

Bleeding / Pain after Renal Biopsy Guideline Bleeding / Pain after Renal Biopsy Guideline This guidance does not override the individual responsibility of health professionals to make appropriate decision according to the circumstances of the individual

More information

28 th September Author Jeremy Gilbert Bariatric Nurse Specialist

28 th September Author Jeremy Gilbert Bariatric Nurse Specialist POLICY FOR SELF ADMINISTRATION OF CONTINUOUS POSITIVE AIRWAY PRESSURE BY COMPETENT PATIENTS COMING IN FOR METABOLIC AND OBESITY SURGERY (BARIATRIC SURGERY) TO PENDENNIS WARD 28 th September 2014 Author

More information

CLINICAL GUIDELINE FOR THE ADMINISTRATION OF NEBULISED PENTAMIDINE Summary. 1.

CLINICAL GUIDELINE FOR THE ADMINISTRATION OF NEBULISED PENTAMIDINE Summary. 1. CLINICAL GUIDELINE FOR THE ADMINISTRATION OF NEBULISED PENTAMIDINE Summary. 1. Patient requires nebulised Pentamidine Ensure equipment listed is available Ensure HEPA filtered room in Haematology Clinic

More information

The Newcastle upon Tyne Hospitals NHS Foundation Trust. Pre-filled Patient Controlled Analgesia (PCA) syringes

The Newcastle upon Tyne Hospitals NHS Foundation Trust. Pre-filled Patient Controlled Analgesia (PCA) syringes The Newcastle upon Tyne Hospitals NHS Foundation Trust Pre-filled Patient Controlled Analgesia (PCA) syringes Version.: 2.2 Effective From: 1 June 2016 Expiry Date: 1 June 2019 Date Ratified: 20 April

More information

SECTION 10: MANAGEMENT OF ALCOHOL, OPIOID AND BENZODIAZEPINE DEPENDENCE. Formulary and Prescribing Guidelines

SECTION 10: MANAGEMENT OF ALCOHOL, OPIOID AND BENZODIAZEPINE DEPENDENCE. Formulary and Prescribing Guidelines SECTION 10: MANAGEMENT OF ALCOHOL, OPIOID AND BENZODIAZEPINE DEPENDENCE Formulary and Prescribing Guidelines 10.1 Introduction This document covers the safe prescribing and management for service users

More information

Prescribing for substance misuse: alcohol detoxification

Prescribing for substance misuse: alcohol detoxification Prescribing for substance misuse: alcohol POMH-UK Quality Improvement Programme. Topic 14b (re-audit) Prepared by the Prescribing Observatory for Mental Health-UK for Non-participating Trusts Published

More information

ALCOHOL ASSESSMENT AND DETOXIFICATION POLICY FOR INPATIENTS

ALCOHOL ASSESSMENT AND DETOXIFICATION POLICY FOR INPATIENTS ALCOHOL ASSESSMENT AND DETOXIFICATION POLICY FOR INPATIENTS Version: 4 Date issued: August 2017 Review date: August 2020 Applies to: All staff working within Trust Inpatient settings This document is available

More information

Benzodiazepines and Hypnotics

Benzodiazepines and Hypnotics Benzodiazepines and Hypnotics Full Title of Guideline: Author (include email and role): Division & Speciality: Scope (Target audience, state if Trust wide): Review date (when this version goes out of date):

More information

Our plans to prescribe fewer medicines that can be bought without a prescription What do you think?

Our plans to prescribe fewer medicines that can be bought without a prescription What do you think? I I rth West London Collaboration of Clinical Commissioning Groups Our plans to prescribe fewer medicines that can be bought without a prescription What do you think? 1 Prescriptions Prescribe is where

More information

Critical Care Pharmacological Management of Delirium

Critical Care Pharmacological Management of Delirium Critical Care Pharmacological Management of Delirium Policy Title: in the Critical Care Unit Executive Summary: This policy provides guidance Pharmacological Management of delirium in the Critical Care

More information

PALIPERIDONE LONG ACTING INJECTION PRESCRIBING GUIDELINE. Chief Pharmacist. Chief Pharmacist

PALIPERIDONE LONG ACTING INJECTION PRESCRIBING GUIDELINE. Chief Pharmacist. Chief Pharmacist REFERENCE NUMBER: PALIPERIDONE LONG ACTING INJECTION PRESCRIBING GUIDELINE AREA: NAME OF RESPONSIBLE COMMITTEE / INDIVIDUAL NAME OF ORIGINATOR / AUTHOR Trust-wide Chief Pharmacist Chief Pharmacist DATE

More information

A Guide to Alcoholism and Problem Drinking

A Guide to Alcoholism and Problem Drinking A Guide to Alcoholism and Problem Drinking Alcoholism is a word which many people use to mean alcohol dependence (alcohol addiction). Some people are problem drinkers without being dependent on alcohol.

More information

Guidance for community alcohol detoxification in clients with complex needs

Guidance for community alcohol detoxification in clients with complex needs Document level: Clinical Service Unit (CSU) Code: DA3 Issue number: 1 Guidance for community alcohol detoxification in clients with complex needs Lead executive Medical Director Author and contact number

More information

High Dose Antipsychotic Therapy (HDAT) guideline

High Dose Antipsychotic Therapy (HDAT) guideline Document level: Trustwide (TW) Code: MP18 Issue number: 2 High Dose Antipsychotic Therapy (HDAT) guideline Lead executive Medical Director Author and contact number Lead Clinical Pharmacist 01625 663 857

More information

SOUTH WEST LONDON & ST GEORGE S MENTAL HEATH NHS TRUST SMOKE FREE POLICY

SOUTH WEST LONDON & ST GEORGE S MENTAL HEATH NHS TRUST SMOKE FREE POLICY SOUTH WEST LONDON & ST GEORGE S MENTAL HEATH NHS TRUST SMOKE FREE POLICY The primary function of the National Health Service is to improve health, cure the sick and alleviate suffering in the population.

More information

NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE. Proposed Health Technology Appraisal

NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE. Proposed Health Technology Appraisal NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE Proposed Health Technology Appraisal Nalmefene for reducing alcohol consumption in people with alcohol dependence Draft scope (pre-referral) Draft remit/appraisal

More information

Falls The Assessment, Prevention and Management of Patient Falls (Adult Services) 1.34

Falls The Assessment, Prevention and Management of Patient Falls (Adult Services) 1.34 SECTION: 1 PATIENT CARE Including Physical Healthcare POLICY /PROCEDURE: 1.34 NATURE AND SCOPE: SUBJECT (Title): POLICY AND PROCEDURE - TRUST WIDE FALLS: THE ASSESSMENT, PREVENTION AND MANAGEMENT OF PATIENT

More information

DIAGNOSIS AND MANAGEMENT OF PYLORIC STENOSIS IN CHILDREN CLINICAL GUIDELINE V3.0

DIAGNOSIS AND MANAGEMENT OF PYLORIC STENOSIS IN CHILDREN CLINICAL GUIDELINE V3.0 DIAGNOSIS AND MANAGEMENT OF PYLORIC STENOSIS IN CHILDREN CLINICAL GUIDELINE V3.0 1. Aim/Purpose of this Guideline This guideline is relevant to all medical and nursing staff caring for children with Pyloric

More information

Alcohol Issues in the Acute General Hospital Setting

Alcohol Issues in the Acute General Hospital Setting Alcohol Issues in the Acute General Hospital Setting (Guidelines and Management) This procedural document supersedes: PAT/T 25 version 2 - Guidelines for the Management of Alcohol Issues in the Acute General

More information

Managing presenting alcohol users an Introduction to SPECTRUM (CRI) By Dr Gideon Felton MRCPsych Consultant Psychiatrist and Clinical Lead

Managing presenting alcohol users an Introduction to SPECTRUM (CRI) By Dr Gideon Felton MRCPsych Consultant Psychiatrist and Clinical Lead Managing presenting alcohol users an Introduction to SPECTRUM (CRI) By Dr Gideon Felton MRCPsych Consultant Psychiatrist and Clinical Lead PLAN OF PRESENTATION Assessment of alcohol dependence Psychiatric

More information

METABOLIC BONE DISEASE OF PREMATURITY NEONATAL CLINICAL GUIDELINE V3.0

METABOLIC BONE DISEASE OF PREMATURITY NEONATAL CLINICAL GUIDELINE V3.0 METABOLIC BONE DISEASE OF PREMATURITY NEONATAL CLINICAL GUIDELINE V3.0 Page 1 of 10 1. Aim/Purpose of this Guideline To provide guidance on the prevention of metabolic bone disease in the neonate. All

More information

IT and Information Acceptable Use Policy

IT and Information Acceptable Use Policy BMI IMpol04 Information Management IT and Information Acceptable Use Policy This is a controlled document and whilst this document may be printed, the electronic version posted on the intranet/shared drive

More information

Title Alcohol Withdrawal Management Guidelines

Title Alcohol Withdrawal Management Guidelines Document Control Title Alcohol Withdrawal Management Guidelines Author Directorate Date Version Issued 0.1 Dec 2009 0.2 Mar 2010 0.3 Nov 2010 Status Draft 0.4 Sep 2015 1.0 Jan 2016 2.0 Nov Final 2018 Main

More information

WAHT-T&O-006 It is the responsibility of every individual to check that this is the latest version/copy of this document.

WAHT-T&O-006 It is the responsibility of every individual to check that this is the latest version/copy of this document. OPERATIONAL GUIDELINES FOR OCCUPATIONAL THERAPY ASSESSMENT AND TREATMENT OF ADULTS WITH TRAUMATIC HEAD INJURY ADMITTED/TRANSFERRED OR ATTENDING A&E AT WORCESTERSHIRE ROYAL HOSPITAL This guidance does t

More information

MANAGEMENT AND DETOXIFICATION FOR GAMMA- HYDROXYBUTYRATE (GHB) AND GAMMA-BUTARYL LACTONE (GBL) GUIDELINES SEPTEMBER 2017

MANAGEMENT AND DETOXIFICATION FOR GAMMA- HYDROXYBUTYRATE (GHB) AND GAMMA-BUTARYL LACTONE (GBL) GUIDELINES SEPTEMBER 2017 MANAGEMENT AND DETOXIFICATION FOR GAMMA- HYDROXYBUTYRATE (GHB) AND GAMMA-BUTARYL LACTONE (GBL) GUIDELINES SEPTEMBER 2017 Policy title Management and Detoxification for GHB and GBL Policy PHA61 reference

More information

CLINICAL GUIDELINE FOR THE MANAGEMENT OF BARRETT S OESOPHAGUS Summary.

CLINICAL GUIDELINE FOR THE MANAGEMENT OF BARRETT S OESOPHAGUS Summary. CLINICAL GUIDELINE FOR THE MANAGEMENT OF BARRETT S OESOPHAGUS Summary. Page 1 of 12 Recurrent LGD at any point- discuss at MDT And consider RFA Patients with LGD should have a repeat endoscopy in 6 months.

More information

ORIGINAL INVESTIGATION. Symptom-Triggered vs Fixed-Schedule Doses of Benzodiazepine for Alcohol Withdrawal

ORIGINAL INVESTIGATION. Symptom-Triggered vs Fixed-Schedule Doses of Benzodiazepine for Alcohol Withdrawal Symptom-Triggered vs Fixed-Schedule Doses of Benzodiazepine for Alcohol Withdrawal A Randomized Treatment Trial ORIGINAL INVESTIGATION Jean-Bernard Daeppen, MD; Pascal Gache, MD; Ulrika Landry, BA; Eva

More information

NO SMOKING POLICY. Organisational

NO SMOKING POLICY. Organisational NO SMOKING POLICY Policy Title State previous title where relevant. State if Policy New or Revised Policy Strand Org, HR, Clinical, H&S, Infection Control, Finance For clinical policies only - state index

More information

Substance Misuse Nurse service Belfast Trust

Substance Misuse Nurse service Belfast Trust Substance Misuse Nurse service Belfast Trust Alcohol is the most widely available socially acceptable drug in Northern Ireland It can be an addictive substance It is a depressant- slows down the central

More information

LOCAL EQUALITY ADVISORY FORUM (LEAF) A Staffordshire CCGs Equality & Inclusion Group. Terms of Reference

LOCAL EQUALITY ADVISORY FORUM (LEAF) A Staffordshire CCGs Equality & Inclusion Group. Terms of Reference LOCAL EQUALITY ADVISORY FORUM (LEAF) A Staffordshire CCGs Equality & Inclusion Group Terms of Reference (1) Introduction and Purpose Promoting equality and inclusion is at the heart of our values. We will

More information

Out of Hours Emergency Enteral Feeding Regimen (Including Risk Reduction for Re-feeding Syndrome)

Out of Hours Emergency Enteral Feeding Regimen (Including Risk Reduction for Re-feeding Syndrome) Out of Hours Emergency Enteral Feeding Regimen (Including Risk Reduction for Re-feeding Syndrome) This guidance does not override the individual responsibility of health professionals to make appropriate

More information

MANAGEMENT OF THE BLADDER IN THE POSTOPERATIVE PERIOD FOLLOWING UNCOMPLICATED GYNAECOLOGICAL SURGERY CLINICAL GUIDELINES

MANAGEMENT OF THE BLADDER IN THE POSTOPERATIVE PERIOD FOLLOWING UNCOMPLICATED GYNAECOLOGICAL SURGERY CLINICAL GUIDELINES MANAGEMENT OF THE BLADDER IN THE POSTOPERATIVE PERIOD FOLLOWING UNCOMPLICATED GYNAECOLOGICAL SURGERY CLINICAL GUIDELINES 1. Aim/Purpose of this Guideline All clinical staff working in the Division of women,

More information

Community alcohol detoxification in primary care

Community alcohol detoxification in primary care Community alcohol detoxification in primary care 1. Purpose The purpose of this primary care enhanced service is to improve the health and quality of life of people whose health may be compromised by their

More information

Alcohol Interventions: NICE guidelines and beyond. Professor Colin Drummond

Alcohol Interventions: NICE guidelines and beyond. Professor Colin Drummond Alcohol Interventions: NICE guidelines and beyond Professor Colin Drummond What this presentation covers Background Scope Methodology What is new? Implications for practice Implementation International

More information

Administration of High Dose Intra- Muscular Vitamin Supplements for Patients Undergoing Alcohol Detoxification. Standard Operating Procedure

Administration of High Dose Intra- Muscular Vitamin Supplements for Patients Undergoing Alcohol Detoxification. Standard Operating Procedure Administration of High Dose Intra- Muscular Vitamin Supplements for Patients Undergoing Alcohol Detoxification Standard Operating Procedure DOCUMENT CONTROL: Version: 3 Ratified by: Quality Assurance Sub

More information

*IN10 BIOPSYCHOSOCIAL ASSESSMENT*

*IN10 BIOPSYCHOSOCIAL ASSESSMENT* BIOPSYCHOSOCIAL ASSESSMENT 224-008B page 1 of 5 / 06-14 Please complete this questionnaire and give it to your counselor on your first visit. This information will help your clinician gain an understanding

More information

ROLE OF HEALTH CARE PROVIDERS IN THE MANAGEMENT OF ALCOHOL AND DRUG USE RELATED PROBLEMS

ROLE OF HEALTH CARE PROVIDERS IN THE MANAGEMENT OF ALCOHOL AND DRUG USE RELATED PROBLEMS ROLE OF HEALTH CARE PROVIDERS IN THE MANAGEMENT OF ALCOHOL AND DRUG USE RELATED PROBLEMS Dr. Anita Rao? ASK SCREEN Refer HELP T T Ranganathan Clinical Research Foundation TTK Hospital IV Main Road, Indira

More information

Critical Care Pharmacological Management of Delirium

Critical Care Pharmacological Management of Delirium Critical Care Pharmacological Management of Delirium Policy Title: in the Critical Care Unit Executive Summary: This policy provides guidance Pharmacological Management of delirium in the Critical Care

More information

SMOKING POLICY. Version Control Version No: 3 Implementation Date March 2006 Last Review Date March 2006 Next Formal Review Date May 2010

SMOKING POLICY. Version Control Version No: 3 Implementation Date March 2006 Last Review Date March 2006 Next Formal Review Date May 2010 SMOKING POLICY Version Control Date Version No: 3 Implementation Date March 2006 Last Review Date March 2006 Next Formal Review Date May 2010 Impact Assessment Date August 2010 Engagement and Consultation

More information

Detoxification in the Community Policy Incorporating the Administration of Pabrinex Intramuscular Procedure. Version No.1.1

Detoxification in the Community Policy Incorporating the Administration of Pabrinex Intramuscular Procedure. Version No.1.1 Livewell Southwest Detoxification in the Community Policy Incorporating the Administration of Pabrinex Intramuscular Procedure Version No.1.1 Review Date: July 2020 Expiry Date: January 2021 Notice to

More information

Initiation of Clozapine Treatment Community Patients

Initiation of Clozapine Treatment Community Patients Initiation of Clozapine Treatment Community Patients Who Should Read This Policy Target Audience All clinical staff working in the community N/A N/A Initiation of Clozapine Treatment for Patients in the

More information

CAUTION: Refer to the Document Library for the most recent version of this policy. Policy for the use of Cytomegalovirus (CMV) negative blood products

CAUTION: Refer to the Document Library for the most recent version of this policy. Policy for the use of Cytomegalovirus (CMV) negative blood products Directorate Department Year Version Number Central Index Number Endorsing Committee Date Endorsed Approval Committee Date Approved Author Name and Job Title Key Words (for search purposes) Date Published

More information

Developed By Name Signature Date

Developed By Name Signature Date Patient Group Direction 2155 version 2.0 Administration / Supply of Inhaled Salbutamol in Asthma by Registered Practitioners employed by Torbay and South Devon NHS Foundation Trust Date of Introduction:

More information

WAHT-OCT-021 It is the responsibility of every individual to ensure this is the latest version as published on the Trust Intranet

WAHT-OCT-021 It is the responsibility of every individual to ensure this is the latest version as published on the Trust Intranet This guidance does not override the individual responsibility of health professionals to make appropriate decision according to the circumstances of the individual patient in consultation with the patient

More information

Date: 22nd March 2018 Our Ref: FANitaminMGPG/Mar18 Enquiries to Frances Adamson Extension: Direct Line: f.adamsonanhs.

Date: 22nd March 2018 Our Ref: FANitaminMGPG/Mar18 Enquiries to Frances Adamson Extension: Direct Line: f.adamsonanhs. NHS Grampian Westholme Woodend Hospital Queens Road ABERDEEN AB15 6LS NHS Grampian Date: 22nd March 2018 Our Ref: FANitaminMGPG/Mar18 Enquiries to Frances Adamson Extension: 56689 Direct Line: 01224 556689

More information

Clinical guideline Published: 23 February 2011 nice.org.uk/guidance/cg115

Clinical guideline Published: 23 February 2011 nice.org.uk/guidance/cg115 Alcohol-use disorders: diagnosis, assessment and management of harmful drinking and alcohol dependence Clinical guideline Published: 23 February 2011 nice.org.uk/guidance/cg115 NICE 2018. All rights reserved.

More information

Alcohol use disorders: diagnosis and clinical management of alcohol-related physical complications

Alcohol use disorders: diagnosis and clinical management of alcohol-related physical complications Alcohol use disorders: diagnosis and clinical management of alcohol-related physical complications NICE guideline Draft for consultation, September 2009 If you wish to comment on this version of the guideline,

More information

School Hearing Screening Policy

School Hearing Screening Policy School Hearing Screening Policy V2.1 1st August 2017 Page 1 of 13 Table of Contents 1. Introduction... 3 2. Purpose of this Policy... 3 3. Scope... 3 4. Definitions / Glossary... 3 5. Ownership and Responsibilities...

More information

Dementia Care Pathway

Dementia Care Pathway Document level: West Locality Code: CC41 Issue number: 1 Dementia Care Pathway Lead executive Authors details Type of document Target audience Document purpose Medical Director Dr Anushta Sivananthan Dr

More information

SHARED CARE GUIDELINE FOR RIFAXIMIN FOR PREVENTING EPISODES OF OVERT HEPATIC ENCEPHALOPATHY IN ADULT PATIENTS 1. Aim/Purpose of this Guideline

SHARED CARE GUIDELINE FOR RIFAXIMIN FOR PREVENTING EPISODES OF OVERT HEPATIC ENCEPHALOPATHY IN ADULT PATIENTS 1. Aim/Purpose of this Guideline SHARED CARE GUIDELINE FOR RIFAXIMIN FOR PREVENTING EPISODES OF OVERT HEPATIC ENCEPHALOPATHY IN ADULT PATIENTS 1. Aim/Purpose of this Guideline 1.1. This guideline applies to medical, nursing and pharmacy

More information

PATIENT GROUP DIRECTION PROCEDURE

PATIENT GROUP DIRECTION PROCEDURE PATIENT GROUP DIRECTION PROCEDURE Date approved 2 October 2015 Version 3 Approved by Yvette Oade, Chief Medical Officer Procedure Lead Clinical Governance Lead - Medicines Management Procedure Author Karen

More information

Commissioning Policy. Treatment of Snoring. April 2010

Commissioning Policy. Treatment of Snoring. April 2010 Commissioning Policy Treatment of Snoring April 2010 This commissioning policy applies to patients within: South Worcestershire Clinical Commissioning Group (CCG) Redditch & Bromsgrove Clinical Commissioning

More information

PABRINEX PRESCRIBING PROTOCOL JULY This policy supersedes all previous policies for medically assisted community alcohol withdrawal

PABRINEX PRESCRIBING PROTOCOL JULY This policy supersedes all previous policies for medically assisted community alcohol withdrawal PABRINEX PRESCRIBING PROTOCOL JULY 2015 This policy supersedes all previous policies for medically assisted community alcohol withdrawal Policy title Policy PHA55 reference Policy category Clinical Relevant

More information

DRAFT FOR CONSULTATION

DRAFT FOR CONSULTATION 1) What is the accuracy of a tool and/or clinical judgement for the a) assessment b) monitoring of patients at risk of acute alcohol withdrawal? 2) Does the assessment and monitoring of patients with acute

More information

CLINICAL GUIDELINE FOR MANAGEMENT OF NEUTROPENIC SEPSIS IN ADULT CANCER PATIENTS (this guideline excludes haematology patients)

CLINICAL GUIDELINE FOR MANAGEMENT OF NEUTROPENIC SEPSIS IN ADULT CANCER PATIENTS (this guideline excludes haematology patients) CLINICAL GUIDELINE FOR MANAGEMENT OF NEUTROPENIC SEPSIS IN ADULT CANCER PATIENTS (this guideline excludes haematology patients) 1. Aim/Purpose of this Guideline 1.1. Systemic cancer treatments and immunological

More information

MERSEY CARE NHS TRUST HOW WE MANAGE MEDICINES. MM11 - High-Dose Antipsychotic Use Guidelines (local guideline) KEY ISSUES

MERSEY CARE NHS TRUST HOW WE MANAGE MEDICINES. MM11 - High-Dose Antipsychotic Use Guidelines (local guideline) KEY ISSUES MERSEY CARE NHS TRUST HOW WE MANAGE MEDICINES MM11 - High-Dose Antipsychotic Use Guidelines (local guideline) Medicines Management Services aim to ensure that (i) Service users receive their medicines

More information

Fasting for Adults (including Young Adults Age 16+ years) who require Anaesthesia or Intravenous Sedation Clinical Guideline V5.0

Fasting for Adults (including Young Adults Age 16+ years) who require Anaesthesia or Intravenous Sedation Clinical Guideline V5.0 Fasting for Adults (including Young Adults Age 16+ years) who require Anaesthesia or Intravenous Sedation November 2018 Summary. Fasting for Adults (including Young Adults Age 16+ years) who require Anaesthesia

More information

HYPOSPADIAS NEONATAL CLINICAL GUIDELINE. 1. Aim/Purpose of this Guideline. 2. The Guidance

HYPOSPADIAS NEONATAL CLINICAL GUIDELINE. 1. Aim/Purpose of this Guideline. 2. The Guidance HYPOSPADIAS NEONATAL CLINICAL GUIDELINE 1. Aim/Purpose of this Guideline 1.1. This guideline applies to all staff managing the initial care of infants born with hypospadias. It includes assessment and

More information

Patient Group Directions (PGDs)

Patient Group Directions (PGDs) Patient Group Directions (PGDs) Document level: Trustwide (TW) Code: MP2 Issue number: 4 Lead executive Authors details Type of document Target audience Document purpose Medical Director Senior Clinical

More information

Clinical Guideline / Formulary Document Pharmacy Department Medicines Management Services

Clinical Guideline / Formulary Document Pharmacy Department Medicines Management Services Clinical Guideline / Formulary Document Pharmacy Department Medicines Management Services SUBSTANCE DEPENDENCY For full details of the of the medication discussed in this formulary including side effects,

More information

PAIN AND SYMPTOM MANAGEMENT GUIDANCE IN THE LAST DAYS OF LIFE

PAIN AND SYMPTOM MANAGEMENT GUIDANCE IN THE LAST DAYS OF LIFE PAIN AND SYMPTOM MANAGEMENT GUIDANCE IN THE LAST DAYS OF LIFE Reference: DCM029 Version: 1.1 This version issued: 07/06/18 Result of last review: Minor changes Date approved by owner (if applicable): N/A

More information